COSCIENS Biopharma Inc. (TSX:CSCI)
Canada
· Delayed Price · Currency is CAD 4.450
+0.110 (2.53%)
Apr 24, 2025, 4:00 PM EDT
COSCIENS Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 16.39 | 6.68 | 50.61 | 65.3 | 24.27 | Upgrade
|
| Cash & Short-Term Investments | 16.39 | 6.68 | 50.61 | 65.3 | 24.27 | Upgrade
|
| Cash Growth | 145.48% | -86.80% | -22.50% | 169.04% | 209.66% | Upgrade
|
| Accounts Receivable | 1.88 | 0.13 | 0.4 | 0.88 | 1.19 | Upgrade
|
| Other Receivables | 0.59 | 0.16 | 1.76 | 2.8 | 1.09 | Upgrade
|
| Receivables | 2.47 | 0.29 | 2.16 | 3.68 | 2.28 | Upgrade
|
| Inventory | 2.69 | 4.01 | 0.23 | 0.07 | 0.02 | Upgrade
|
| Prepaid Expenses | 1.7 | 0.08 | 0.43 | 0.42 | 1.02 | Upgrade
|
| Other Current Assets | 0.73 | 0.21 | 2.06 | 1.35 | 0.02 | Upgrade
|
| Total Current Assets | 23.98 | 11.27 | 55.49 | 70.82 | 27.61 | Upgrade
|
| Property, Plant & Equipment | 10.97 | 11.65 | 0.22 | 0.19 | 0.18 | Upgrade
|
| Goodwill | - | - | - | 8.13 | 8.82 | Upgrade
|
| Other Intangible Assets | - | 0.01 | - | 0.63 | 0.06 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.08 | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.12 | 0.75 | 0.32 | 0.34 | 0.34 | Upgrade
|
| Total Assets | 35.07 | 23.75 | 56.03 | 80.1 | 37.01 | Upgrade
|
| Accounts Payable | 2.41 | 0.28 | 2.04 | 0.93 | 1.19 | Upgrade
|
| Accrued Expenses | 2.37 | 0.73 | 1.79 | 1.74 | 1.01 | Upgrade
|
| Current Portion of Leases | 0.27 | 0.3 | 0.11 | 0.13 | 0.14 | Upgrade
|
| Current Income Taxes Payable | 0.11 | - | 0.11 | 0.12 | 0.12 | Upgrade
|
| Current Unearned Revenue | 0.12 | - | 2.95 | 4.82 | 2.19 | Upgrade
|
| Other Current Liabilities | 1.95 | - | 0.05 | 0.03 | 0.09 | Upgrade
|
| Total Current Liabilities | 7.22 | 1.31 | 7.04 | 7.77 | 4.74 | Upgrade
|
| Long-Term Leases | 2.04 | 1.4 | 0.07 | 0.03 | 0.05 | Upgrade
|
| Long-Term Unearned Revenue | 0.91 | - | 1.79 | 1.59 | 3.29 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.19 | 0.24 | 0.28 | Upgrade
|
| Total Liabilities | 21.91 | 2.71 | 20.25 | 27.12 | 23.79 | Upgrade
|
| Common Stock | 22.49 | 13.52 | 293.41 | 293.41 | 235.01 | Upgrade
|
| Additional Paid-In Capital | - | - | 90.33 | - | - | Upgrade
|
| Retained Earnings | -12.11 | 4.36 | -352.08 | -334.62 | -322.66 | Upgrade
|
| Comprehensive Income & Other | 2.79 | 3.16 | 4.12 | 94.2 | 100.86 | Upgrade
|
| Shareholders' Equity | 13.16 | 21.04 | 35.78 | 52.99 | 13.21 | Upgrade
|
| Total Liabilities & Equity | 35.07 | 23.75 | 56.03 | 80.1 | 37.01 | Upgrade
|
| Total Debt | 2.31 | 1.7 | 0.18 | 0.16 | 0.18 | Upgrade
|
| Net Cash (Debt) | 14.08 | 4.98 | 50.43 | 65.14 | 24.09 | Upgrade
|
| Net Cash Growth | 182.79% | -90.13% | -22.58% | 170.43% | 247.53% | Upgrade
|
| Net Cash Per Share | 5.46 | 2.70 | 27.19 | 56.68 | 58.63 | Upgrade
|
| Filing Date Shares Outstanding | 3.15 | 1.21 | 1.21 | 1.21 | 1.21 | Upgrade
|
| Total Common Shares Outstanding | 3.14 | 1.21 | 1.21 | 1.21 | 0.63 | Upgrade
|
| Working Capital | 16.76 | 9.96 | 48.44 | 63.05 | 22.87 | Upgrade
|
| Book Value Per Share | 4.19 | 17.33 | 29.47 | 43.65 | 21.08 | Upgrade
|
| Tangible Book Value | 13.16 | 21.03 | 35.78 | 44.23 | 4.34 | Upgrade
|
| Tangible Book Value Per Share | 4.19 | 17.32 | 29.47 | 36.44 | 6.92 | Upgrade
|
| Machinery | 10.9 | 11.98 | 0.45 | 0.47 | 0.55 | Upgrade
|
| Leasehold Improvements | 5.64 | 6.68 | - | - | - | Upgrade
|
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.